Mark Macnealy
Neurology · West Chester, OHNPI 1861838922
Payments from drug & device makers
Across 319 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$973
- Otsuka America Pharmaceutical, Inc.$823
- Sunovion Pharmaceuticals Inc.$737
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$535
- Vanda Pharmaceuticals Inc.$457
- Teva Pharmaceuticals USA, Inc.$415
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,713100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 42 | $973 |
| Otsuka America Pharmaceutical, Inc. | 45 | $823 |
| Sunovion Pharmaceuticals Inc. | 58 | $737 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $535 |
| Vanda Pharmaceuticals Inc. | 25 | $457 |
| Teva Pharmaceuticals USA, Inc. | 18 | $415 |
| Neurocrine Biosciences, Inc. | 30 | $354 |
| Alkermes, Inc. | 35 | $321 |
| Axsome Therapeutics, Inc. | 15 | $311 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $198 |
| AbbVie(2 entities) | 5 | $186 |
| Idorsia Pharmaceuticals US Inc | 6 | $176 |
| Lundbeck LLC | 6 | $93 |
| Merck | 2 | $29 |
| Corium, LLC | 2 | $28 |
| Indivior Inc. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,716 in reported general payments places this provider in the 60th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Adderall XrDextroamphetamine/Amphetamine | 20 | $6,306 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 39 | $1,637 |
| Ziprasidone Hcl | 11 | $888 |
| Trazodone Hcl | 27 | $813 |
| Buspirone Hcl | 23 | $577 |
| Hydroxyzine Pamoate | 13 | $160 |
| Lithium Carbonate | 18 | $60 |
| Clonidine Hcl | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other neurology in West Chester
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
- Robert BermelCleveland$6.4M
- Aaron BosterColumbus$6.3M
- Ryan DrakeCanton$5.5M
- Aram ZabetiCincinnati$5.3M
- Mark StillmanIndependence$4.6M
- Deren HuangNewark$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.